Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02724163
Title International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia (Myechild01)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors University of Birmingham
Indications

myelodysplastic syndrome

myeloid sarcoma

acute myeloid leukemia

Therapies

Gemtuzumab ozogamicin

Busulfan + Fludarabine

Cytarabine

Cytarabine + Fludarabine

Cytarabine + Daunoxome

Busulfan + Cyclophosphamide

Cytarabine + Mitoxantrone

Age Groups: child
Covered Countries


No variant requirements are available.